PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 7 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ethanol extract (100 mg/kg intraperitoneal) prevented lesion development [PMID:22014743]. Pure compounds (ferulic acid, rosmarinic acid, and caffeic acid) administered intralesionally at 30 mg/kg controlled lesion size and parasite burden in mice [PMID:24906989]. Essential oils inhibited growth of promastigotes and amastigotes in vitro [PMID:28703380].
Extracts demonstrated interesting antifungal activities, suggesting potential for use in formulations against superficial mycoses and deep fungal infections [PMID:23280633].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 22014743 (2011) — Antileishmanial assessment of leaf extracts from Pluchea carolinensis, Pluchea odorata and Pluchea rosea. · Asian Pacific journal of tropical medicine
- 2.PMID: 16564648 (2006) — Evaluation of Pluchea carolinensis extracts as antioxidants by the epinephrine oxidation method. · Fitoterapia
- 3.PMID: 24906989 (2014) — In vitro and in vivo activity of major constituents from Pluchea carolinensis against Leishmania amazonensis. · Parasitology research
- 4.PMID: 23280633 (2013) — Antifungal activity of 10 Guadeloupean plants. · Phytotherapy research : PTR
- 5.PMID: 28703380 (2017) — Chemical Characterization, Antileishmanial Activity, and Cytotoxicity Effects of the Essential Oil from Leaves of Pluchea carolinensis (Jacq.) G. Don. (Asteraceae).